Foundayo (Orforglipron) Approval Marks the Beginning of the Oral GLP-1 Era for Obesity Treatment
1. The FDA approved orforglipron (Foundayo) on April 1, 2026, making it the first non-peptide oral GLP-1 receptor agonist cleared ...
Tag: adherence
Oral semaglutide reshapes everyday obesity visits
1. Oral semaglutide adds a pill-based option for chronic obesity care without changing the core GLP-1 tradeoffs in efficacy and ...
Personalized risk messages may not increase colorectal cancer screening uptake
1. In this randomized controlled trial, using personalized risk messages and provider notifications did not significantly increase screening uptake overall. ...
Tailored care approaches may improve glaucoma medication adherence
1. In a meta-analysis of 19 randomized controlled trials, tailored care with and without additional interventions was associated with significant ...
Cost-related medication nonadherence associated with increased ED utilization
Image: PD 1. Among Medicare beneficiaries studied, 7.5% reported a reduction in dose or delay in filling medications, and 8.2% ...
